• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Identification of novel genetic loci for risk of multiple myeloma by functional annotation.

作者信息

Macauda Angelica, Briem Klara, Clay-Gilmour Alyssa, Cozen Wendy, Försti Asta, Giaccherini Matteo, Corradi Chiara, Sainz Juan, Niazi Yasmeen, Ter Horst Rob, Li Yang, Netea Mihai G, Vogel Ulla, Hemminki Kari, Slager Susan L, Varkonyi Judit, Andersen Vibeke, Iskierka-Jazdzewska Elzbieta, Mártinez-Lopez Joaquin, Zaucha Jan, Camp Nicola J, Rajkumar S Vincent, Druzd-Sitek Agnieszka, Bhatti Parveen, Chanock Stephen J, Kumar Shaji K, Subocz Edyta, Mazur Grzegorz, Landi Stefano, Machiela Mitchell J, Jerez Andrés, Norman Aaron D, Hildebrandt Michelle A T, Kadar Katalin, Berndt Sonja I, Ziv Elad, Buda Gabriele, Nagler Arnon, Dumontet Charles, Raźny Malgorzata, Watek Marzena, Butrym Aleksandra, Grzasko Norbert, Dudzinski Marek, Rybicka-Ramos Malwina, Matera Eva-Laure, García-Sanz Ramón, Goldschmidt Hartmut, Jamroziak Krzysztof, Jurczyszyn Artur, Clavero Esther, Giles Graham G, Pelosini Matteo, Zawirska Daria, Kruszewski Marcin, Marques Herlander, Haastrup Eva, Sánchez-Maldonado José Manuel, Bertsch Uta, Rymko Marcin, Raab Marc-Steffen, Brown Elizabeth E, Hofmann Jonathan N, Vachon Celine, Campa Daniele, Canzian Federico

机构信息

Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

出版信息

Leukemia. 2023 Nov;37(11):2326-2329. doi: 10.1038/s41375-023-02022-8. Epub 2023 Sep 18.

DOI:10.1038/s41375-023-02022-8
PMID:37723249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10624610/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e1/10624610/3950b88bb032/41375_2023_2022_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e1/10624610/3950b88bb032/41375_2023_2022_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e1/10624610/3950b88bb032/41375_2023_2022_Fig1_HTML.jpg

相似文献

1
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.通过功能注释鉴定多发性骨髓瘤风险的新基因位点
Leukemia. 2023 Nov;37(11):2326-2329. doi: 10.1038/s41375-023-02022-8. Epub 2023 Sep 18.
2
A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.非洲和欧洲裔人群多发性骨髓瘤风险区域的荟萃分析确定了可能具有功能的基因座。
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1609-1618. doi: 10.1158/1055-9965.EPI-15-1193. Epub 2016 Sep 1.
3
Genetic variation at the 8q24 locus confers risk to multiple myeloma.8q24基因座的遗传变异会增加患多发性骨髓瘤的风险。
Br J Haematol. 2012 Jan;156(1):133-6. doi: 10.1111/j.1365-2141.2011.08798.x. Epub 2011 Jul 19.
4
Genetic predisposition for multiple myeloma.多发性骨髓瘤的遗传易感性。
Leukemia. 2020 Mar;34(3):697-708. doi: 10.1038/s41375-019-0703-6. Epub 2020 Jan 8.
5
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.3p22.1 和 7p15.3 常见变异影响多发性骨髓瘤风险。
Nat Genet. 2011 Nov 27;44(1):58-61. doi: 10.1038/ng.993.
6
Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma.全基因组相互作用和基于途径的多发性骨髓瘤关键调控因子的鉴定。
Commun Biol. 2019 Mar 4;2:89. doi: 10.1038/s42003-019-0329-2. eCollection 2019.
7
HLA polymorphism and risk of multiple myeloma.人类白细胞抗原多态性与多发性骨髓瘤风险
Leukemia. 2016 Nov;30(11):2260-2264. doi: 10.1038/leu.2016.199. Epub 2016 Jul 27.
8
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.7p15.3、3p22.1和2p23.3基因座的多态性变异对多发性骨髓瘤风险的影响。
Br J Haematol. 2012 Sep;158(6):805-9. doi: 10.1111/j.1365-2141.2012.09244.x. Epub 2012 Jul 24.
9
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.鉴定多个影响多发性骨髓瘤易感性的风险位点和调控机制。
Nat Commun. 2018 Sep 13;9(1):3707. doi: 10.1038/s41467-018-04989-w.
10
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.对 IMMEnSE 联盟 8q24 区域的遗传变异与多发性骨髓瘤风险的全面研究。
Br J Haematol. 2012 May;157(3):331-8. doi: 10.1111/j.1365-2141.2012.09047.x. Epub 2012 Feb 13.

引用本文的文献

1
Multiple myeloma.多发性骨髓瘤。
Nat Rev Dis Primers. 2024 Jun 27;10(1):45. doi: 10.1038/s41572-024-00529-7.

本文引用的文献

1
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer.PANcreatic Disease ReseArch（PANDoRA）联盟：通过关联研究了解胰腺癌遗传结构的十年经验。
Crit Rev Oncol Hematol. 2023 Jun;186:104020. doi: 10.1016/j.critrevonc.2023.104020. Epub 2023 May 8.
2
CTCF: A misguided jack-of-all-trades in cancer cells.CTCF：癌细胞中一个被误导的多面手。
Comput Struct Biotechnol J. 2022 May 27;20:2685-2698. doi: 10.1016/j.csbj.2022.05.044. eCollection 2022.
3
A novel regQTL-SNP and the risk of lung cancer: a multi-dimensional study.
一种新型的 regQTL-SNP 与肺癌风险：一项多维研究。
Arch Toxicol. 2021 Dec;95(12):3815-3827. doi: 10.1007/s00204-021-03170-5. Epub 2021 Oct 1.
4
Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses.职业暴露与多发性骨髓瘤风险：荟萃分析的最新综述
J Clin Med. 2021 Sep 16;10(18):4179. doi: 10.3390/jcm10184179.
5
STK10 knockout inhibits cell migration and promotes cell proliferation via modulating the activity of ERM and p38 MAPK in prostate cancer cells.STK10基因敲除通过调节ERM和p38丝裂原活化蛋白激酶的活性抑制前列腺癌细胞的迁移并促进其增殖。
Exp Ther Med. 2021 Aug;22(2):851. doi: 10.3892/etm.2021.10283. Epub 2021 Jun 8.
6
Leveraging functional annotation to identify genes associated with complex diseases.利用功能注释来识别与复杂疾病相关的基因。
PLoS Comput Biol. 2020 Nov 2;16(11):e1008315. doi: 10.1371/journal.pcbi.1008315. eCollection 2020 Nov.
7
Genetic predisposition for multiple myeloma.多发性骨髓瘤的遗传易感性。
Leukemia. 2020 Mar;34(3):697-708. doi: 10.1038/s41375-019-0703-6. Epub 2020 Jan 8.
8
Multiple myeloma.多发性骨髓瘤。
Nat Rev Dis Primers. 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46.
9
Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells.干扰素调节因子 1（IRF-1）诱导细胞周期停滞依赖于 p21（WAF1/CIP1）和非依赖于 p21（WAF1/CIP1）的调节肿瘤细胞中的存活素。
Cancer Lett. 2012 Jun 1;319(1):56-65. doi: 10.1016/j.canlet.2011.12.027. Epub 2011 Dec 23.
10
IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo.IRF-1表达在体外和体内均可诱导小鼠乳腺癌细胞凋亡并抑制肿瘤生长。
Oncogene. 2004 Feb 5;23(5):1125-35. doi: 10.1038/sj.onc.1207023.